http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109498625-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
| filingDate | 2018-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109498625-B |
| titleOfInvention | Pharmaceutical composition for treating chronic obstructive pulmonary disease and preparation method thereof |
| abstract | The invention relates to a pharmaceutical composition for treating chronic obstructive pulmonary disease and a preparation method thereof, wherein the pharmaceutical composition takes xanthenedione and optional glucocorticoid as active ingredients, and can be administered through gastrointestinal tract or inhaled after being added with pharmaceutically acceptable carriers. The combination of xanthethidione, xanthethidione and glucocorticoid can effectively improve the lung function of chronic obstructive pulmonary diseases and relieve the clinical symptoms of the chronic obstructive pulmonary diseases, wherein the combination of xanthethidione and glucocorticoid can remarkably reduce the effective dose of glucocorticoid while maintaining similar treatment effect, thereby remarkably reducing the side effect of glucocorticoid. |
| priorityDate | 2018-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.